An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Phase of Trial: Phase II
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Beclometasone
- Indications Asthma
- Focus Therapeutic Use
- Acronyms BEAM
- Sponsors Chiesi Farmaceutici SpA
- 02 Nov 2017 Status changed from not yet recruiting to recruiting.
- 24 Mar 2017 New trial record